Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

Objective. Drug survival rate and time are important to demonstrate the effectiveness of treatment in patients with axial spondyloarthritis (axSpA) in real life. Therefore, we aimed to evaluate drug survival rate and predictors of discontinuation of certolizumab and secukinumab in axSpA patients....

Full description

Saved in:
Bibliographic Details
Main Authors: Ebru Atalar, Hatice Ecem Konak, Pınar Akyüz Dağlı, Bahar Özdemir Ulusoy, Özlem Karakaş, Kevser Orhan, Rezan Koçak Ulucaköy, Esra Kayacan Erdoğan, Serdar Can Güven, Orhan Küçükşahin, İsmail Doğan, Hakan Babaoğlu, Yüksel Maraş, Şükran Erten, Ahmet Omma, Berkan Armağan
Format: Article
Language:English
Published: PAGEPress Publications 2025-06-01
Series:Reumatismo
Subjects:
Axial spondyloarthritis
biological drug
certolizumab pegol
secukinumab
survival analysis
Online Access:https://www.reumatismo.org/reuma/article/view/1792
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.reumatismo.org/reuma/article/view/1792

Similar Items